Sorafenib-Inhibited Signaling: Emerging Evidence of RAFIndependent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma
None
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2013
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/45179 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Sorafenib-Inhibited Signaling: Emerging Evidence of RAFIndependent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma
- Sorafenib in the Continuum of Care for Hepatocellular Carcinoma: Challenges in Defining Optimal Practice
- Molecular Mechanism of DNA Damage Response Pathway During Hepatic Carcinogenesis
- Tissue Factor Pathway Inhibitor-2 Inhibits the Growth and Invasion of Hepatocellular Carcinoma Cells and is Inactivated in Human Hepatocellular Carcinoma
- Novel Therapeutic Targets for Hepatocellular Carcinoma Treatment
- Hepatocellular Carcinoma
- Post-Therapeutic Follow-Up and Early Detection of Recurrence in Hepatocellular Carcinoma